PT - JOURNAL ARTICLE AU - Houwaart, Torsten AU - Belhaj, Samir AU - Tawalbeh, Emran AU - Nagels, Dirk AU - Finzer, Patrick AU - Fröhlich, Yara AU - Benmoumene, Assia AU - Asskali, Dounia AU - Haidar, Hussein AU - von Dahlen, Janina AU - Nicolai, Jessica AU - Stiller, Lisa AU - Blum, Jacqueline AU - Lange, Christian AU - Adelmann, Carla AU - Schroer, Britta AU - Osmers, Ute AU - Grice, Christiane AU - Kirfel, Phillipp P. AU - Jomaa, Hassan AU - Strelow, Daniel AU - Hülse, Lisanna AU - Pigulla, Moritz AU - Kreuzer, Pascal AU - Tyshaieva, Alona AU - Weber, Jonas AU - Wienemann, Tobias AU - Vasconcelos, Malte Kohns AU - Hoffmann, Katrin AU - Lübke, Nadine AU - Hauka, Sandra AU - Andree, Marcel AU - Jürgen Scholz, Claus AU - Jazmati, Nathalie AU - Göbels, Klaus AU - Zotz, Rainer AU - Pfeffer, Klaus AU - Timm, Jörg AU - Ehlkes, Lutz AU - Walker, Andreas AU - Dilthey, Alexander T. AU - , TI - Integrated Genomic Surveillance reveals extensive onward transmission of travel-imported SARS-CoV-2 infections in the community AID - 10.1101/2021.10.18.21264530 DP - 2021 Jan 01 TA - medRxiv PG - 2021.10.18.21264530 4099 - http://medrxiv.org/content/early/2021/10/26/2021.10.18.21264530.short 4100 - http://medrxiv.org/content/early/2021/10/26/2021.10.18.21264530.full AB - Integration of genomic surveillance with contact tracing provides a powerful tool for the reconstruction of person-to-person pathogen transmission chains. We report two large clusters of SARS-CoV-2 cases (“Delta” clade, 110 cases combined) detected in July 2021 by Integrated Genomic Surveillance in Düsseldorf. Structured interviews and deep contact tracing demonstrated an association to a single SARS-CoV-2 infected return traveller (Cluster 1) and to return travel from Catalonia and other European countries (Cluster 2), highlighting the importance of containing travel-imported SARS-CoV-2 infections.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Ministry for Work, Health and Social Affairs of the State of North Rhine-Westphalia; the Jürgen Manchot Foundation; the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung; award numbers 031L0184B and 01KX2021); the German Research Foundation (award 428994620).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our study was IRB-approved by the ethics committee of the Heinrich Heine University Düsseldorf (#2020-839).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesFASTA files and the phylogenetic tree of all Düsseldorf and Solingen samples have been made available via OSF (DOI 10.17605/OSF.IO/B7TU3). All viral genome assemblies from Düsseldorf surveillance samples that meet GISAID quality criteria have also been submitted to GISAID. Accessions are listed in Supplementary Table 1. https://osf.io/b7tu3/ https://www.gisaid.org/